efficacy
The Problem of Inflated Efficacy in Psychiatry Journals
Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial
This research paper has been published in eClinicalMedicine. The summary says: “Background Psilocybin has been suggested as a novel, rapid-acting treatment for depression. Two consecutive doses have been shown to markedly decrease symptom severity in an open-label setting or when compared to…
Read more
Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants’ Efficacy and Harm
This paper by Michael Hengartner has been published in the journal Frontiers in Psychiatry. The abstract says: “Background In current psychiatric practice, antidepressants are widely and with ever-increasing frequency prescribed to patients. However, several scientific biases obfuscate estimates of antidepressants’ efficacy…
Read more
The Visual Illusion of Efficacy in Psychiatric Drug Trials
Is medical research now beyond redemption?
“… without so called ‘evidence’ there is no seat at the guideline table. This is the fundamental ‘commissioning bias,’ the elephant in the room, because the drug industry controls and funds most research. So the drug industry and EBM [evidence…
Read more